PNPLA3 and metabolic dysfunction-associated steatohepatitis: The primary focus of this pilot study was the determination of the gene frequency of polymorphisms in the PNPLA3 gene, which is implicated as an important factor in liver disease progression in patients with ASH and NAFLD/NASH.